Senior insider sale
EVP, Global Operations at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$1.08M
33.49K shares
What this filing means
SHIELDS MATTHEW plans to sell 33.49K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $1.08M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/3/2026ACC: 0001973379-26-000220
Officer· EVP, Global Operations
Since Mar 2026
33.49K
Shares to sell
$1.08M
Approx. market value
16.20K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
RESTRICTED SHARE UNIT AWARD VESTING
COMPENSATION
6/3/2024
16.20KTotal acquired16.20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/3/2024 | RESTRICTED SHARE UNIT AWARD VESTING COMPENSATION | 16.20K | — |
| Total | 16.20K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
17.30K
Market value
$547.7K
3/5/2026
Planned — Approximate Date
NYSEPlanned
Units to sell
16.20K
Market value
$532.3K
6/3/2026
Total
Units
33.49K
Value
$1.08M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/5/2026 | 17.30K | $547.7K | — | Completed |
| Planned — Approximate Date | ||||
6/3/2026 | 16.20K | $532.3K | NYSE | Planned |
| Total | 33.49K | $1.08M | ||